Diabetes Technology Skills Workshop-$$ ticketed session

Friday, May 13, 2022

1:30 PM – 5:00 PM

Location: Sapphire 410 AB (Level 4)

Speaker(s)

Madhuri Vasudevan, MD, MPH
Assistant Professor Director Diabetes Program Michael E. DeBakey VA Med Center
Baylor College of Medicine
Pearland, TX, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

PDF Slides
GD

Georgia M. Davis, MD
Assistant Professor
Emory University
Atlanta, Georgia, United States

Disclosure: Insulet (Self) : Research Grant (Status: Ongoing), University Grants/Research Support (Status: Ongoing)

PDF Slides

Faculty(s)

Rodolfo J. Galindo, MD, FACE
Emory University
Atlanta, Georgia, United States

Disclosure: Abbott Diabetes (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 12/31/2018); Dexcom (Self) : University Grants/Research Support (Status: Ongoing); Eli Lilly (Self) : Research Grant (Status: Ongoing); Novo Nordisk (Self) : University Grants/Research Support (Status: Ongoing); Sanofi (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Valeritas (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 12/31/2019); Weight Watchers (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing)
Roma Gianchandani, MBBS
Professor of Medicine
Cedars Sinai Health System

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Neda Rasouli, MD
University of Colorado, Colorado, United States

Disclosure: Novo Nordisk (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing)
Viral N. Shah, MD
Associate Professor
Barbara Davis Center for Diabetes, University of Colorado
Aurora, Colorado, United States

Disclosure: Dexcom (Self) : Research Grant (Status: Ongoing); Eli-Lilly (Self) : Grant/Research Support (Status: Ongoing); Insulet (Self) : Grant/Research Support (Status: Ongoing); Medscape LLC (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Novo Nordisk (Self) : Grant/Research Support (Status: Ongoing); Sanofi (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- ); Tandem Diabetes Care (Self) : Research Grant (Status: Ongoing)
Jeff Unger, MD
Director
Unger Primary Care Concierge Medical Group
RANCHO CUCAMONGA, California, United States

Disclosure: Abbott Diabetes (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Grant/Research Support (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Bayer (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Dexcom (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Novo Nordisk (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Shareholder (Status: Ongoing); Sanofi (Self) : Honorarium (Status: Ongoing)
Archana Sadhu, MD, FACE
Director, System Diabetes Program and Director, Transplant Endocrinology
Houston Methodist
Houston, TX, United States

Disclosure: Abbott (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing)

Chair(s)

Cecilia C. Low Wang, MD
Professor of Medicine
University of Colorado Anschutz Medical Campus School of Medicine
Aurora, Colorado, United States

Disclosure: Dexcom Inc (Self) : Research Grant (Status: Ongoing)

Co-Chair(s)

Rifka Schulman-Rosenbaum, MD, FACE, CNSC
Director of Inpatient Diabetes, Associate Professor of Medicine
Division of Endocrinology, Diabetes and Metabolism Long Island Jewish Medical Center, Northwell Health Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
New Hyde Park, New York, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Faculty(s)

Joyce R. Spalding, MSN, RN, PHN, CDCES
Clinical Program Coordinator
Cedars-Sinai Medical Center
Los Angeles, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Erica Patel, MD
Endocrinology Fellow
Cedars Sinai Medical Center
Los Angeles, California, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

NOTE: Pre-Registration required. This workshop has a $75 supplies charge.

AGENDA
1:30 pm-2:00 pm Overview of Diabetes Technology---Georgia Davis, MD
2:00 pm-3:00 pm Case Studies: Interpreting Pump and CGM Downloads---Madhuri Vasudevan, MD
3:15 pm-4:30 pm STATIONS: CGM Pumps Pens---ALL FACULTY
4:30 pm-5:00 pm Questions and Answers--ALL FACULTY

Learning Objectives:

Discuss current insulin pumps and CGM devices on the market
Decipher basic and advanced concepts of statistical interpretation of blood glucose data
Assess CGM /pumps through live demonstrations
Discuss the use and limitations of diabetes technology in specific patient cases from real world clinical setting.

Participants should be aware of the following financial/non-financial relationships:

Madhuri Vasudevan, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Georgia M. Davis, MD: Insulet (Individual(s) Involved: Self): Research Grant, University Grants/Research Support

Rodolfo J. Galindo, MD, FACE: Abbott Diabetes (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Dexcom (Individual(s) Involved: Self): University Grants/Research Support; Eli Lilly (Individual(s) Involved: Self): Research Grant; Novo Nordisk (Individual(s) Involved: Self): University Grants/Research Support; Sanofi (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Valeritas (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Weight Watchers (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards)

Roma Gianchandani, MBBS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Neda Rasouli, MD: Novo Nordisk (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Consulting Fees (e.g., advisory boards), Research Grant

Viral N. Shah, MD: Dexcom (Individual(s) Involved: Self): Research Grant; Eli-Lilly (Individual(s) Involved: Self): Grant/Research Support; Insulet (Individual(s) Involved: Self): Grant/Research Support; Medscape LLC (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Novo Nordisk (Individual(s) Involved: Self): Grant/Research Support; Sanofi (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Tandem Diabetes Care (Individual(s) Involved: Self): Research Grant

Jeff Unger, MD: Abbott Diabetes (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Grant/Research Support, Honorarium, Research Grant; Bayer (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Dexcom (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Novo Nordisk (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Honorarium, Shareholder; Sanofi (Individual(s) Involved: Self): Honorarium

Archana Sadhu, MD, FACE: Abbott (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards)

Cecilia C. Low Wang, MD: Dexcom Inc (Individual(s) Involved: Self): Research Grant

Rifka Schulman-Rosenbaum, MD, FACE, CNSC: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Joyce R. Spalding, MSN, RN, PHN, CDCES: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Erica Patel, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.